Biotech trends in COVID era: the pharmaphorum podcastIn episode 26 the pharmaphorum podcast hears from David Solomon, a 30-year life sciences industry veteran who recently Share XBiotech trends in COVID era: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/biotech-trends-pharnext-david-solomon/
3 ways health tech is rising to the COVID challengeFrom AI-driven vaccine candidate selection to the mass roll-out of virtual consultations, digital transformation is accelerating at an Share X3 ways health tech is rising to the COVID challengehttps://pharmaphorum.com/views-analysis-digital/3-ways-health-tech-is-rising-to-the-covid-challenge/
5 ways electronic health records are boosting patient outcomesThanks to the backing of governments and policymakers the world over, electronic health records have become more prevalent Share X5 ways electronic health records are boosting patient outcomeshttps://pharmaphorum.com/views-analysis-digital/5-ways-electronic-health-records-are-boosting-patient-outcomes/
How digital is reversing fortunes in R&DA new report lays out the ways digital transformation could reverse the trend of declining ROI in pharma Share XHow digital is reversing fortunes in R&Dhttps://pharmaphorum.com/views-analysis-digital/digital-reversing-fortunes-rd/
Roche, big data and patient outcomes: the pharmaphorum podcastIn the first pharmaphorum podcast of 2020 Roche’s Conor Megaw talks about his company’s approach to big data Share XRoche, big data and patient outcomes: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/roche-big-data-and-patient-outcomes/
Novartis taps Microsoft’s AI expertise for drug developmentNovartis has forged an alliance with Microsoft that will apply artificial intelligence and machine-learning to the discovery, development Share XNovartis taps Microsoft’s AI expertise for drug developmenthttps://pharmaphorum.com/news/novartis-taps-microsofts-ai-expertise-for-drug-development/
How can biotechnology, pharmaceutical and medical device companies achieve the full potential of content personalisation?By Carlos Casanova Healthcare and life sciences companies have an unrealised opportunity to maximise the benefits of personalising Share XHow can biotechnology, pharmaceutical and medical device companies achieve the full potential of content personalisation?https://pharmaphorum.com/views-analysis-sales-marketing/full-potential-content-personalisation/
The top 10 ways digital will transform healthcareJanssen’s Kris Sterkens gives his thoughts on how digital will continue to influence healthcare in the age of Share XThe top 10 ways digital will transform healthcarehttps://pharmaphorum.com/views-analysis-digital/the-top-10-ways-digital-will-transform-healthcare/
Company profile: EvideraData disruption and applying ‘enabled intelligence’ to convert the promise shown in clinical trials into real-world success. For Share XCompany profile: Eviderahttps://deep-dive.pharmaphorum.com/magazine/disruptive-technologies/data-disruption-and-applying-enabled-intelligence/
